FAIRFAX, Va. (PRWEB) December 15, 2020
The life sciences industry is a dynamic environment of science and technology. Quality and Regulatory Compliance (QRC) are foundational elements of this ecosystem that permit the thorough investigation of new medicines, precise manufacturing of new devices, and speedy development of innovative therapies. Rapid growth, dynamic teams, and frequent mergers & acquisitions within the Pharmaceutical, Biotech, and Medical Device communities are continuously stoking changes to business operations. Therefore, a QRC foundation must be able to adapt with confidence while also providing uninterrupted compliance.
There is a constant tug of war between the inertia of time-worn legacy systems and the frenetic energy and motivation of innovative teams to perform more effectively. This continuous tension creates a plethora of possibilities to improve QRC with robust new technologies. The 2030 Consulting team (pronounced Twenty-Thirty) has worked extensively in the QRC arena for decades. Based on our experience, we believe that three priorities should drive modern QRC technology efforts: Scalability, Sustainability, and Resilience.